Tone mix
Week by week 52 weeks
Share of Relay Therapeutics, Inc. Common Stock's 132 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Oct 13, 2025 · tone -100Relay Therapeutics' (RLAY) "Sell (D-)" Rating Reiterated at Weiss Ratings-125
- Week of May 11, 2026 · tone +100H.C. Wainwright is Bullish on Relay Therapeutics, Inc. (RLAY)+82
- Week of Jun 1, 2026 · tone +100Relay Therapeutics Shares Jump 18%+74
- Week of Apr 21, 2025 · tone +100Relay Therapeutics (RLAY): The Most Promising Penny Stock According to Analysts+73
- Week of Jun 8, 2026 · tone +100Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why+73
- Week of Apr 27, 2026 · tone -33Relay Therapeutics (RLAY) Falls Hard on Profit-Taking From 74% April Jump-72
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Relay Therapeutics, Inc. Common Stock in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | 0 |
| Last 30 sessions | 7 | 0 |
| Last 90 sessions | 31 | +15 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.manilatimes.net · 1 outletRelay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Relay Therapeutics to Announce Third Quarter 2026 Financial Results and Corporate Highlights on November 4, 2026 | www.manilatimes.net | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletContrasting Relay Therapeutics (NASDAQ:RLAY) and Praxis Precision Medicines (NASDAQ:PRAX)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Contrasting Relay Therapeutics (NASDAQ:RLAY) and Praxis Precision Medicines (NASDAQ:PRAX) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 12, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletHead-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Head-To-Head Comparison: Krystal Biotech (NASDAQ:KRYS) and Relay Therapeutics (NASDAQ:RLAY) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.themarketsdaily.com · 1 outletRelay Therapeutics (NASDAQ:RLAY) CEO Sanjiv Patel Sells 48,199 Shares of StockNeutral
- www.dailypolitical.com · 1 outletRelay Therapeutics (NASDAQ:RLAY) Stock: Insider Sanjiv Patel Sells 48,199 SharesNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Relay Therapeutics (NASDAQ:RLAY) CEO Sanjiv Patel Sells 48,199 Shares of Stock | www.themarketsdaily.com | 1 | Neutral |
| Relay Therapeutics (NASDAQ:RLAY) Stock: Insider Sanjiv Patel Sells 48,199 Shares | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 5, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletFinancial Survey: Ernexa Therapeutics (NASDAQ:ERNA) vs. Relay Therapeutics (NASDAQ:RLAY)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Financial Survey: Ernexa Therapeutics (NASDAQ:ERNA) vs. Relay Therapeutics (NASDAQ:RLAY) | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Relay Therapeutics, Inc. Common Stock, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.